El abordaje debe ser integral | 26 ENE 19

Trastornos de ansiedad y por consumo de alcohol

La coexistencia entre los trastornos de ansiedad y los trastornos por consumo de alcohol es frecuente y tiene consecuencias clínicas y terapéuticas negativas.
Autor/a: Gimeno C, Dorado M, Alvarez F y colaboradores Frontiers in Psychiatry 8(-):1-14, Sep 2017
INDICE:  1. Página 1 | 2. Página 2
Página 2


1. Ipser JC, Wilson D, Akindipe TO, Sager C, Stein DJ. Pharmacotherapy for anxiety and comorbid alcohol use disorders. Cochrane Database Syst Rev (2015) 20(1):CD007505. doi:10.1002/14651858.CD007505.pub2

2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Pub (2013). Available from: https://www.appi.org/products/dsm-manual-of-mental-disorders

3. Global Status Report on Alcohol and Health. Geneva: WHO (2014). Available from: http://www.who.int/substance_abuse/publications/global_ alcohol_report/en/

4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Text Revision. 4th ed. American Psychiatric Pub (2000). Available from: http://dsm.psychiatryonline.org/doi/abs/10.1176/appi. books.9780890420249.dsm-iv-tr

5. National Institute on Drug Addiction. DrugFacts: Comorbidity: Addiction and Other Mental Disorders. (2011). Available from: https://www.drugabuse. gov/publications/drugfacts/comorbidity-addiction-other-mental-disorders

6. EMCDDA. Comorbidity of Substance Use and Mental Disorders in Europe: A Review of the Data. EMCDDA Papers. Luxembourg: Publications Office of the European Union (2015). Available from: http://www.emcdda.europa.eu/ publications/insights/comorbidity-substance-use-mental-disorders-europe

7. Roncero C, Ortega L, Pérez-Pazos J, Lligoña A, Abad AC, Gua A, et al. Psychiatric comorbidity in treatment-seeking alcohol dependence patients with and without ADHD. J Atten Disord (2015). doi:10.1177/1087054715598841

8. Sáiz PA, Díaz EM, García-Portilla MP, Marina P, Bobes J, Szerman N. Patologia Dual. Protocolos de Intervención. Ansiedad. (2011). Available from: http://www.patologiadual.es/docs/protocolos_patologiadual_modulo4.pdf

9. Daigre C, Roncero C, Rodríguez-Cintas L, Ortega L, Lligoña A, Fuentes S, et  al. Adult ADHD screening in alcohol-dependent patients using the Wender-Utah rating scale and the adult ADHD self-report scale. J Atten Disord (2015) 19(4):328–34. doi:10.1177/ 1087054714529819

10. Szerman N, Arias F, Vega P, Babín F, Mesías B, Basurte I, et al. Pilot study on the prevalence of dual pathology in community mental health and substance misuse services in Madrid. Adicciones (2011) 23(3):249–55. doi:10.20882/adicciones.149

11. Lev-Ran S, Imtiaz S, Rehm J, Le Foll B. Exploring the association between lifetime prevalence of mental illness and transition from substance use to substance use disorders: results from the National Epidemiologic Survey of Alcohol and Related Conditions (NESARC). Am J Addict (2013) 22(2):93–8. doi:10.1111/j.1521-0391.2013.00304.x

12. Buckner JD, Schmidt NB, Lang AR, Small JW, Schlauch RC, Lewinsohn PM. Specificity of social anxiety disorder as a risk factor for alcohol and cannabis dependence. J Psychiatr Res (2008) 42(3):230–9. doi:10.1016/j.jpsychires.2007.01.002

13. Boden JM, Fergusson DM. Alcohol and depression. Addiction (2011) 106:906–14. doi:10.1111/j.1360-0443.2010.03351.x

14. Grant BF, Saha TD, Ruan WJ, Goldstein RB, Chou SP, Jung J, et  al. Epidemiology of DSM-5 drug use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiatry (2016) 73(1):37–47. doi:10.1001/jamapsychiatry.2015.2132

15. McHugh K. Treatment of co-occurring anxiety disorders and substance abuse disorders. Harv Rev Psychiatry (2015) 23(2):99–111. doi:10.1097/ HRP.0000000000000058

16. Torrens M, Gilchrist G, Domingo-Salyany A; PsyCo Barcelona Group. Psychiatric comorbidity in illicit drug users: substance-induced versus independent disorders. Drug Alcohol Depend (2011) 113(2–3):147–56. doi:10.1016/j.drugalcdep.2010.07.013

17. Kushner MG, Sher KJ, Beitman BD. The relation between alcohol problems and the anxiety disorders. Am J Psychiatry (1990) 147(6):685–95. doi:10.1176/ ajp.147.6.685

18. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry (1985) 142(11):1259–64. doi:10.1176/ajp.142.11.1259

19. Brady KT, Lydiard RB. The association of alcoholism and anxiety. Psychiatr Q (1993) 64(2):135–49. doi:10.1007/BF01065866

20. Morris EP, Stewart SH, Ham LS. The relationship between social anxiety disorder and alcohol use disorders: a critical review. Clin Psychol Rev (2005) 25(6):734–60. doi:10.1016/j.cpr.2005.05.004

21. Wolitzky-Taylor K, Guillot CR, Pang RD, Kirkpatrick MG, Zvolensky MJ, Buckner JD, et al. Examination of anxiety sensitivity and distress tolerance as transdiagnostic mechanisms linking multiple anxiety pathologies to alcohol use problems in adolescents. Alcohol Clin Exp Res (2015) 39(3):532–9. doi:10.1111/acer.12638

22. Kendall PC, Safford S, Flannery-Schroeder E, Webb A. Child anxiety treatment: outcomes in adolescence and impact on substance use and depression at 7.4-year followup. J Consult Clin Psychol (2004) 72(2):276–87. doi:10.1037/0022-006X.72.2.276

23. Costardi JV, Nampo RA, Silva GL, Ribeiro MA, Stella HJ, Stella MB, et al. A review on alcohol: from the central action mechanism to chemical dependency. Rev Assoc Med Bras (2015) 61(4):381–7. doi:10.1590/1806-9282.61. 04.381

24. Erdozain AM, Callado LF. Neurobiological alterations in alcohol addiction: a review. Adicciones (2014) 26(4):360–70. doi:10.20882/adicciones.40

25. Mifflin K, Benson C, Kerr B, Aricioglu F, Cetin M, Dursun S, et  al. Involvement of neuroactive steroids in pain, depression and anxiety. Mod Trends Pharmacopsychiatry (2015) 30:94–102. doi:10.1159/000435935

26. Holmes A, Spanagel R, Krystal JH. Glutamatergic targets for new alcohol medications. Psychopharmacology (Berl) (2013) 229(3):539–54. doi:10.1007/ s00213-013-3226-2

27. de la peña JB, Cheong JH. The abuse liability of the NMDA receptor antagonist-benzodiazepine (tiletamine-zolazepam) combination: evidence from clinical case reports and preclinical studies. Drug Test Anal (2016) 8(8):760–7. doi:10.1002/dta.1987

28. Cloninger CR, Sigvardsson S, Gilligan SB, von Knorring AL, Reich T, Bohman M. Genetic heterogeneity and the classification of alcoholism. Adv Alcohol Subst Abuse (1988) 7(3–4):3–16. doi:10.1300/J251v07n03_02

29. Babor TF, Hofmann M, DelBoca FK, Hesselbrock V, Meyer RE, Dolinsky ZS, et al. Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry (1992) 49(8):599–608. doi:10.1001/archpsyc.1992.01820080007002

30. Ball SA. Type A and Type B Alcoholism. Applicability across Subpopulations and Treatment Settings. (2016). Available from: http://www.emcdda.europa. eu/system/files/publications/1988/TDXD15019ENN.pdf

31. Arias F, Szerman N, Vega P, Mesias B, Basurte I, Morant C, et al. Estudio Madrid sobre prevalencia y características de los pacientes con patología dual en tratamiento en las redes de salud mental y de atención al drogodependiente. Adicciones (2013) 25(2):118–27. doi:10.20882/adicciones.59

32. Conway KP, Swendsen J, Husky MM, He JP, Merikangas KR. Association of lifetime mental disorders and subsequent alcohol and illicit drug use: results from the national comorbidity survey-adolescent supplement. J Am Acad Child Adolesc Psychiatry (2016) 55(4):280–8. doi:10.1016/j.jaac.2016.01.006

33. Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry (1996) 66(1):17–31. doi:10.1037/h0080151

34. Petrakis IL, González G, Rosenheck R, Krystal JH. Comorbidity of alcoholism and psychiatric disorders. Alcohol Res Health (2002) 26:81–90.

35. Klimkiewicz A, Klimkiewicz J, Jakubczyk A, Kieres-Salomonski I, Wojnar M. Comorbidity of alcohol dependence with other psychiatric disorders. Part I. Epidemiology of dual diagnosis. Psychiatr Pol (2015) 49(2): 265–75. doi:10.12740/PP/26071

36. Compton WM III, Cottler LB, Jacobs JL, Ben-Abdallah A, Spitznagel EL. The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry (2003) 160(5):890–5. doi:10.1176/appi.ajp.160.5.890

37. Rounsaville BJ, Dolinsky ZS, Babor TF, Meyer RE. Psychopathology as a predictor of treatment outcome in alcoholics. Arch Gen Psychiatry (1987) 44(6):505–13. doi:10.1001/archpsyc.1987.01800180015002

38. Brown SA, Irwin M, Schuckit MA. Changes in anxiety among abstinent male alcoholics. J Stud Alcohol (1991) 52(1):55–61. doi:10.15288/jsa.1991. 52.55

39. Kushner MG, Abrams K, Thuras P, Hanson KL, Brekke M, Sletten S. Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcohol Clin Exp Res (2005) 29(8):1432–43. doi:10.1097/01.alc.0000175072.17623.f8

40. Balanzá-Martínez V, Crespo-Facorro B, González-Pinto A, Vieta E. Bipolar disorder comorbid with alcohol use disorder: focus on neurocognitive correlates. Front Physiol (2015) 6:108. doi:10.3389/fphys.2015.00108

41. Álvarez FJ. La prescripción de fármacos fuera de indicación en patología dual: hoja de información al paciente y consentimiento. Rev Patol Dual (2014) 1(3):12. doi:10.17579/RevPatDual.01.12

42. Barral C, Ros-Cucurull E, Roncero C. Prescripción “off-label” en patología dual. Rev Patol Dual (2014) 1(3):10. doi:10.17579/RevPatDual.01.10

43. Dorado M. Uso de fármacos fuera de indicación en patología dual, necesidad clínica. Rev Patol Dual (2014) 1(3):11. doi:10.17579/RevPatDual.01.11

44. Agency of Healthcare Research Quality. Comparative Effectiveness Review. Number 43 Off-Label Use of Atypical Antipsychotics: An Update. (2016). Available from: http://www.patologiadual.es/publishingimages/revista/ pdfs/2014_10.pdf

45. Lingford-Hughes AR, Welch S, Peters L, Nutt DJ; British Association for Psychopharmacology, Expert Reviewers Group. BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol (2012) 26(7):899–952. doi:10.1177/0269881112444324

46. OCEBM Table of Evidence Working Group, Howick J, Chalmers I, Glasziou P, et  al. Oxford Centre for Evidence-Based Medicine (OCEBM). (2011). Available from: http://www.cebm.net/index.aspx?o=5653

47. Wolitzky-Taylor K, Brown LA, Roy-Byrne P, Sherbourne C, Stein MB, Sullivan G, et  al. The impact of alcohol use severity on anxiety treatment outcomes in a large effectiveness trial in primary care. J Anxiety Disord (2015) 30:88–93. doi:10.1016/j.janxdis.2014.12.011

48. Hasin DS, Stinson FS, Ogburn E, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: result from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry (2007) 64:830–42. doi:10.1001/ archpsyc.64.7.830

49. Schneider U, Altmann A, Baumann M, Bernzen J, Bertz B, Bimber U, et al. Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: the first multicentre study in Germany. Alcohol Alcohol (2001) 36(3):219–23. doi:10.1093/alcalc/36.3.219

50. Brady KT, Grice DE, Dustan L, Randall C. Gender differences in substance use disorders. Am J Psychiatry (1993) 150(11):1707–11. doi:10.1176/ ajp.150.11.1707

51. Brady KT, Randall CL. Gender differences in substance use disorders. Psychiatr Clin North Am (1999) 22(2):241–52. doi:10.1016/S0193-953X(05)70074-5

52. Rice KG, van Arsdale AC. Perfectionism, perceived stress, drinking to cope, and alcohol-related problems among college students. J Couns Psychol (2010) 57:439–50. doi:10.1037/a0020221

53. Timko C, Finney JW, Moos RH. The 8-year course of alcohol abuse: gender differences in social context and coping. Alcohol Clin Exp Res (2005) 29:612–21. doi:10.1097/01.ALC.0000158832.07705.22



Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2023